1
|
Effects of a Combination of Polynucleotide and Hyaluronic Acid for Treating Osteoarthritis. Int J Mol Sci 2024; 25:1714. [PMID: 38338992 PMCID: PMC10855695 DOI: 10.3390/ijms25031714] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2023] [Revised: 01/29/2024] [Accepted: 01/29/2024] [Indexed: 02/12/2024] Open
Abstract
Knee osteoarthritis (OA), an age-related degenerative disease characterized by severe pain and disability, is treated using polynucleotides (PNs) and hyaluronic acid (HA). The intra-articular (IA) injection of HA has been studied extensively in both animal models and in humans; however, the efficacy and mechanisms of action remain unclear. In addition, there has been a paucity of research regarding the use of PN alone or in combination with HA in OA. To investigate the effect of the combined injection of PN and HA in vivo, pathological and behavioral changes were assessed in an OA model. Anterior cruciate ligament transection and medial meniscectomy were performed in Sprague-Dawley rats to create the OA animal model. The locomotor activity improved following PNHA injection, while the OARSI grade improved in the medial tibia and femur. In mild OA, TNFα levels decreased histologically in the PN, HA, and PNHA groups but only the PNHA group showed behavioral improvement in terms of distance. In conclusion, PNHA exhibited anti-inflammatory effects during OA progression and improved locomotor activity regardless of the OARSI grade.
Collapse
|
2
|
Polynucleotide injection treatment for iatrogenic fat atrophy in two patients: Potential for safe volumization in aesthetic medicine. Skin Res Technol 2023; 29:e13439. [PMID: 37632185 PMCID: PMC10423761 DOI: 10.1111/srt.13439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2023] [Revised: 08/01/2023] [Accepted: 08/03/2023] [Indexed: 08/27/2023]
|
3
|
Polynucleotides Suppress Inflammation and Stimulate Matrix Synthesis in an In Vitro Cell-Based Osteoarthritis Model. Int J Mol Sci 2023; 24:12282. [PMID: 37569659 PMCID: PMC10418450 DOI: 10.3390/ijms241512282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2023] [Revised: 07/19/2023] [Accepted: 07/28/2023] [Indexed: 08/13/2023] Open
Abstract
Osteoarthritis (OA) is characterized by degeneration of the joint cartilage, inflammation, and a change in the chondrocyte phenotype. Inflammation also promotes cell hypertrophy in human articular chondrocytes (HC-a) by activating the NF-κB pathway. Chondrocyte hypertrophy and inflammation promote extracellular matrix degradation (ECM). Chondrocytes depend on Smad signaling to control and regulate cell hypertrophy as well as to maintain the ECM. The involvement of these two pathways is crucial for preserving the homeostasis of articular cartilage. In recent years, Polynucleotides Highly Purified Technology (PN-HPT) has emerged as a promising area of research for the treatment of OA. PN-HPT involves the use of polynucleotide-based agents with controlled natural origins and high purification levels. In this study, we focused on evaluating the efficacy of a specific polynucleotide sodium agent, known as CONJURAN, which is derived from fish sperm. Polynucleotides (PN), which are physiologically present in the matrix and function as water-soluble nucleic acids with a gel-like property, have been used to treat patients with OA. However, the specific mechanisms underlying the effect remain unclear. Therefore, we investigated the effect of PN in an OA cell model in which HC-a cells were stimulated with interleukin-1β (IL-1β) with or without PN treatment. The CCK-8 assay was used to assess the cytotoxic effects of PN. Furthermore, the enzyme-linked immunosorbent assay was utilized to detect MMP13 levels, and the nitric oxide assay was utilized to determine the effect of PN on inflammation. The anti-inflammatory effects of PN and related mechanisms were investigated using quantitative PCR, Western blot analysis, and immunofluorescence to examine and analyze relative markers. PN inhibited IL-1β induced destruction of genes and proteins by downregulating the expression of MMP3, MMP13, iNOS, and COX-2 while increasing the expression of aggrecan (ACAN) and collagen II (COL2A1). This study demonstrates, for the first time, that PN exerted anti-inflammatory effects by partially inhibiting the NF-κB pathway and increasing the Smad2/3 pathway. Based on our findings, PN can potentially serve as a treatment for OA.
Collapse
|
4
|
Polydeoxyribonucleotide injection in the treatment of patients with carpal tunnel syndrome: Retrospective preliminary study. Medicine (Baltimore) 2019; 98:e17522. [PMID: 31593124 PMCID: PMC6799494 DOI: 10.1097/md.0000000000017522] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND Corticosteroid injection is beneficial in treating carpal tunnel syndrome (CTS) due to its anti-inflammatory effects. However, its side effects limit widespread usage. Recently, several studies have found that polydeoxyribonucleotide offers anti-inflammatory capabilities with fewer side effects, making it an ideal alternative. Nevertheless, there has been no study on its effectiveness in patients with CTS. Therefore, we evaluate the effectiveness of polydeoxyribonucleotide in patients with CTS. Based on the criteria, 30 patients with CTS who received two-consecutive polydeoxyribonucleotide injections (with a week interval) were initially included. METHOD Patients with CTS were investigated retrospectively. To evaluate the effectiveness of polydeoxyribonucleotide in patients with CTS, numeric rating scale (NRS), cross-sectional area (CSA) of the median nerve, and severity and functional status scores of CTS based on the Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) were assessed. RESULTS There was a significant improvement in the NRS, CSA, and functional and severity scores of BCTQ after two-consecutive polydeoxyribonucleotide injections (P < .05). CONCLUSION In conclusion, although more research is needed to evaluate the effectiveness of polydeoxyribonucleotide in patients with CTS, the findings here suggest that polydeoxyribonucleotide may be a viable alternative to corticosteroids in patients with CTS.
Collapse
|
5
|
Effect of multiple intra-articular injections of polynucleotides on treatment of intractable knee osteoarthritis: A case report. Medicine (Baltimore) 2017; 96:e9127. [PMID: 29245352 PMCID: PMC5728967 DOI: 10.1097/md.0000000000009127] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
RATIONALE Knee osteoarthritis (KOA) is a chronic joint degenerative disease. Intra-articular injection (IAI) of hyaluronic acid (HA) is widely used to treat KOA. However, some HA injections have no effect at all. Polynucleotides (PN) are recently noted as a valid substitute for HA. PATIENT CONCERNS A 61-year-old female was admitted to the pain center with symptoms of pain over the knee and warmth feeling with stiffness in the left knee. The patient reported chronic severe pain in the left knee area despite 6 times IAI of HA. She had past medical history of breast cancer and thyroid cancer. DIAGNOSES She was diagnosed as having KOA. INTERVENTIONS Ultrasound-guided IAI of PN was carried out 3 times in 3 weeks. OUTCOMES She was followed-up for more than 5 months with good improvement in intractable knee pain without any adverse event. LESSONS IAI of PN is an efficient therapeutic option for KOA treatment if HA injection is unsuccessful.
Collapse
|
6
|
A phase III, randomized, double-blind, matched-pairs, active-controlled clinical trial and preclinical animal study to compare the durability, efficacy and safety between polynucleotide filler and hyaluronic acid filler in the correction of crow's feet: a new concept of regenerative filler. J Korean Med Sci 2014; 29 Suppl 3:S201-9. [PMID: 25473210 PMCID: PMC4248006 DOI: 10.3346/jkms.2014.29.s3.s201] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/01/2014] [Accepted: 09/02/2014] [Indexed: 11/20/2022] Open
Abstract
The Rejuran® is a new filler product made from purified polynucleotides. Here we present data from an animal study and a clinical trial to examine the durability, efficacy and safety of the Rejuran® on crow's feet. For the animal study, 25 mice were divided into three groups: Group 1 received phosphate buffered saline (PBS); Group 2 were treated with Yvoire®; and Group 3 were treated with Rejuran®. The durability and efficacy of each treatment were assessed by microscopy and staining. In the clinical trial, 72 patients were randomized to receive Rejuran® treatment for crow's feet on one side and Yvoire-Hydro® on the contralateral side, at a ratio of 1:1. Repeated treatments were performed every two weeks for a total of three times, over a total of 12 weeks' observation. All injections and observations of efficacy and safety were performed by the same two investigators. In the animal study, the Rejuran® group showed similar durability and inflammatory response to the Yvoire® group. Upon efficacy assessment, the Rejuran® group showed the greatest elasticity and collagen composition, and a significant difference in skin surface roughness and wrinkle depth. In the clinical trial, the primary and secondary objective efficacy outcome measure showed no statistical significance between the two groups, and in safety outcomes there were no unexpected adverse effects. Our data suggest that the Rejuran®, as a new regenerative filler, can be useful to reduce wrinkles, by showing evidence for its efficacy and safety.
Collapse
|
7
|
Abstract
There have been significant improvements in the diagnosis and treatment of colorectal cancer over the past 15 years. However, some 30% of patients with colorectal cancer have disseminated disease at presentation, and furthermore, 50% of patients initially believed to be cured by surgery subsequently relapse and die of the disease. Novel treatment concepts based on understanding the molecular signatures that separate tumor from normal epithelium, such as immunotherapy, are aimed at abolishing microscopic residual disease post standard treatment. The authors provide an overview of progress in the development of specific and nonspecific immunotherapies and explain why definition of end-points and early translation of immunotherapy into the adjuvant field are key to effective use of such agents in the clinical setting.
Collapse
|
8
|
Comparative pharmacology of site directed antithrombin agents. Implication in drug development. Thromb Haemost 1995; 74:473-81. [PMID: 8578509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Beside the direct inhibition of thrombin and its regulatory functions, many of the newer antithrombin agents produce several additional effects, unrelated to their anticoagulant actions. Synthetic peptide inhibitors are capable of producing fibrinolytic compromise by virtue of their actions on fibrinolytic enzymes such as t-PA, plasmin, urokinase and protein Ca. In addition, the low molecular weight arginine-containing peptides are also known to produce hemodynamic and hemostatic deficits. The designs of the ongoing clinical trials are largely empirical because of the non-availability of valid pharmacologic and toxicologic data on thrombin inhibitors. In contrast to heparin, none of the thrombin inhibitors produce endogenous release of tissue factor pathway inhibitor (TFPI) in the experimental and clinical settings. These observations suggest that beside the direct inhibition of thrombin, these agents also produce multiple additional effects that can significantly contribute to their pharmacologic and toxicologic profile.
Collapse
|
9
|
The effect of synthetic polynucleotides on the intracellular growth of Brucella abortus in vitro and in vivo. THE BRITISH VETERINARY JOURNAL 1980; 136:175-81. [PMID: 6156736 DOI: 10.1016/s0007-1935(17)32341-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
10
|
|
11
|
|
12
|
An integrated and comparative study of the antiviral effects and other biological properties of the polyinosinic-polycytidylic acid duplex and its mismatched analogues. III. Chronic effects and immunological features. Mol Pharmacol 1976; 12:440-53. [PMID: 180397] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
|
13
|
The immunology of cancer: avenues to immunotherapy. ARIZONA MEDICINE 1973; 30:463-83. [PMID: 4581414] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
14
|
[Specific immunotherapy using cell-mediated immune transfer factor. Preliminary results with semi-purified transfer factor]. ANNALES DE MEDECINE INTERNE 1972; 123:1069-72. [PMID: 4664543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
15
|
Antitumor effects of polynucleotides and theophylline. Cancer Res 1972; 32:1814-9. [PMID: 4345038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
16
|
[Effectiveness of midantan and interferon inducers as means of non-specific prevention of influenza]. ANTIBIOTIKI 1972; 17:734-8. [PMID: 4564362] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
17
|
The protective effect of the interferon inducers tilorone hydrochloride and Poly I:C on experimental tick-borne encephalitis in mice. ARCHIV FUR DIE GESAMTE VIRUSFORSCHUNG 1972; 37:262-6. [PMID: 4337548 DOI: 10.1007/bf01268009] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
18
|
Effect of local or distal therapeutic treatment with polyinosinic-polycytidylic acid on survival of mice with Ehrlich carcinoma. J Natl Cancer Inst 1972; 48:1525-7. [PMID: 5030961] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023] Open
|
19
|
Prophylactic and therapeutic use of poly(I)-poly(C) (poly-D-lysine) against herpesvirus encephalitis in mice. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE. SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE (NEW YORK, N.Y.) 1972; 140:66-71. [PMID: 4338187 DOI: 10.3181/00379727-140-36396] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
20
|
Inhibitory effect of polyinosinic:polycytidylic acid on the growth of transplantable mouse mammary carcinoma. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE. SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE (NEW YORK, N.Y.) 1972; 139:1392-7. [PMID: 5023340 DOI: 10.3181/00379727-139-36370] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
21
|
Rabies in rabbits and mice: protective effect of polyriboinosinic-polyribocytidylic acid. J Infect Dis 1972; 125:345-52. [PMID: 4553077 DOI: 10.1093/infdis/125.4.345] [Citation(s) in RCA: 30] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
|
22
|
Polyadenylic-polyuridylic acid, an adjunct to surgery in the treatment of spontaneous mammary tumors in C3H-He mice and transplantable melanoma in the hamster. Cancer Res 1972; 32:648-9. [PMID: 5061315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
23
|
The influence of polyinosinic-polycytidylic acid complex on experimental acute toxoplasmic retinochoroiditis in rabbits. INVESTIGATIVE OPHTHALMOLOGY 1972; 11:182-8. [PMID: 5012489] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
24
|
Evaluation of an interferon inducer in viral respiratory disease. JAMA 1972; 219:1179-84. [PMID: 4334380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
25
|
Effect of autoclaving on molecular weight distribution and chemotherapeutic activity of clinical samples of poly IC (NSC-120949). CANCER CHEMOTHERAPY REPORTS 1972; 56:31-3. [PMID: 5030807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
26
|
Experimental vaccinial keratoconjunctivitis. Effect of an interferon inducer (polyI:C). ARCHIVES OF OPHTHALMOLOGY (CHICAGO, ILL. : 1960) 1972; 87:211-5. [PMID: 5057871 DOI: 10.1001/archopht.1972.01000020213019] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
27
|
|
28
|
Immunologic-mediated protection of Trypanosoma congolense-infected mice by polyribonucleotides. THE JOURNAL OF PROTOZOOLOGY 1971; 18:661-6. [PMID: 5133126 DOI: 10.1111/j.1550-7408.1971.tb03393.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
29
|
Therapeutic effects of a series of non-viral interferon inducers on a viral-induced leukemia. Can J Microbiol 1971; 17:1259-65. [PMID: 4108803 DOI: 10.1139/m71-202] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
A large group of DBA/2 mice with established Friend virus leukemia was treated with a regimen of non-viral inducers of interferon. Treatment was begun 7 days postinoculation of Friend virus and continued at 7-day intervals through 28 days. Treated mice exhibited an increased mean survival of 19 days, decreased splenomegaly, and lower Friend virus titers in the spleen. Fewer viral particles and reticulum type cells were demonstrated in the spleens of the treated animals, as revealed by electron microscopy. Leukemic and normal mice produced comparable levels of interferon in response to the inducers used.
Collapse
MESH Headings
- Administration, Oral
- Animals
- Antiviral Agents/therapeutic use
- Cytopathogenic Effect, Viral
- Ethylamines/therapeutic use
- Fluorenes/therapeutic use
- Friend murine leukemia virus/isolation & purification
- Injections, Intraperitoneal
- Injections, Subcutaneous
- Interferons/analysis
- Interferons/biosynthesis
- Interferons/blood
- Ketones/therapeutic use
- L Cells
- Leukemia, Experimental/blood
- Leukemia, Experimental/drug therapy
- Leukemia, Experimental/metabolism
- Leukemia, Experimental/pathology
- Mice
- Mice, Inbred Strains
- Microscopy, Electron
- Organ Size
- Placebos
- Poly I-C/therapeutic use
- Polynucleotides/therapeutic use
- Polysaccharides/therapeutic use
- Spleen/analysis
- Spleen/microbiology
- Spleen/pathology
- Staining and Labeling
- Tissue Extracts
- Vesicular stomatitis Indiana virus
Collapse
|
30
|
Effect of poly I:C on infectious bovine rhinotracheitis virus infection in calves. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE. SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE (NEW YORK, N.Y.) 1971; 137:1176-9. [PMID: 4333092 DOI: 10.3181/00379727-137-35750] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
31
|
Amelioration of friend virus leukemia by sequential administration of viral and nonviral interferon inducers. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE. SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE (NEW YORK, N.Y.) 1971; 137:981-7. [PMID: 5105377 DOI: 10.3181/00379727-137-35710] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
32
|
Induction of interferon and host resistance in vivo by double-stranded complexes of copolyribonucleotide of isosinic and guanylic with polyribocytidylic acid. ARCHIV FUR DIE GESAMTE VIRUSFORSCHUNG 1971; 34:105-18. [PMID: 4345742 DOI: 10.1007/bf01241712] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
33
|
|
34
|
Inhibition of spontaneous mammary carcinoma of mice by treatment with interferon and poly I:C. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE. SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE (NEW YORK, N.Y.) 1971; 137:304-5. [PMID: 4325777 DOI: 10.3181/00379727-137-35565] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
35
|
Prophylaxis of experimental rabies with the polyriboinosinic-polyribocytidylic acid complex. J Infect Dis 1971; 123:426-8. [PMID: 5110740 DOI: 10.1093/infdis/123.4.426] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023] Open
|
36
|
The influence of Poly I:C on the course of infection in mice inoculated with West Nile virus. ARCHIV FUR DIE GESAMTE VIRUSFORSCHUNG 1971; 35:1-9. [PMID: 5130442 DOI: 10.1007/bf01249747] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
37
|
[Immuno-adjuvant action of poly IC in mice and its application to the treatment of leukemia L 1210]. COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L'ACADEMIE DES SCIENCES. SERIE D: SCIENCES NATURELLES 1971; 272:170-3. [PMID: 4396529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
38
|
|
39
|
|
40
|
Modification of the response of autochthonous Moloney sarcoma virus-induced tumors to poly I:C by DEAE-dx 1 . Chemotherapy 1971; 16:281-93. [PMID: 5146951 DOI: 10.1159/000220738] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
41
|
|
42
|
|
43
|
|
44
|
[Action of polyriboinosinic acid-polyribocytidylic acid bicatenary complex (poly I:C) on infection caused by various viruses in mice]. ANNALES DE L'INSTITUT PASTEUR 1970; 119:756-60. [PMID: 4323223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
45
|
|
46
|
|
47
|
|
48
|
Effects of poly I-C on the course of infection with Trypanosoma cruzi. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE. SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE (NEW YORK, N.Y.) 1970; 134:885-8. [PMID: 4988184 DOI: 10.3181/00379727-134-34904] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
49
|
Differential effect of a synthetic polyribonucleotide complex on spontaneous and transplanted leukemia in mice. LIFE SCIENCES. PT. 2: BIOCHEMISTRY, GENERAL AND MOLECULAR BIOLOGY 1970; 9:653-9. [PMID: 5478080 DOI: 10.1016/0024-3205(70)90216-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
50
|
Remission induction with Poly IC in patients with acute lymphoblastic leukaemia (preliminary results). REVUE EUROPEENNE D'ETUDES CLINIQUES ET BIOLOGIQUES. EUROPEAN JOURNAL OF CLINICAL AND BIOLOGICAL RESEARCH 1970; 15:671-3. [PMID: 5273145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|